Tim Woodman is a Professor in Sport & Exercise at the School of Psychology and Sport Science , Bangor University. He is a leading expert in Performance Psychology , focusing on personality, stress, anxiety, and risk-taking in elite sports. His groundbreaking theory positions risk as central to human development and performance. Research Interests : Narcissism, anxiety-performance relationships, risk-taking behavior, athlete mental health, agentic emotion regulation. Scientific Contributions : Over 150 peer-reviewed publications, including 2025 studies on cricket mental health, coach support dynamics, and pressure training methodologies in elite sports. Projects : Leads the North West Air Ambulance performance psychology initiative and collaborates with Manchester City Football Club on personality-climate change research. Teaching & Supervision : Accepts PhD students interested in risk-taking, personality, and performance psychology topics.
Jennifer D. Oliva is a Professor of Law at Indiana University Maurer School of Law where she holds the Val Nolan Faculty Fellow position. She maintains significant interdisciplinary affiliations as a Research Scholar at Georgetown University Law Center's O'Neill Institute for National & Global Health Law and as a Senior Scholar with the UCSF/UC Law Consortium on Law, Science & Health Policy. Her academic work bridges legal scholarship with practical health policy development, focusing on the intersection of constitutional protections, public health needs, and modern surveillance technologies. Professor Oliva's research interests center on health law, privacy law, and drug policy with particular expertise in prescription drug monitoring programs (PDMPs), health information privacy, and the legal dimensions of the opioid crisis. Her scholarship critically examines how law enforcement surveillance of prescription data impacts patient privacy rights, particularly for vulnerable populations including those with substance use disorders. She has developed significant expertise in how constitutional privacy protections apply to health data in the digital age, especially following the Supreme Court's decision in Carpenter v. United States. Her recent publications reveal a growing focus on algorithmic regulation in healthcare, examining how risk scoring systems and coverage algorithms can perpetuate health disparities. She has published extensively on the intersection of reproductive rights and health data privacy in the post-Dobbs landscape, analyzing how prescription monitoring systems could be weaponized against individuals seeking reproductive healthcare. Her work consistently connects doctrinal legal analysis with public health realities, advocating for evidence-based policy approaches that prioritize patient privacy and health equity over punitive enforcement. Dosing Discrimination: Regulating PDMP Risk Scores (2022) The "New" Drug War (2024) Prescription Drug Policing: The Right to Health Information Privacy Pre- and Post-Carpenter (2020) Opioid Multidistrict Litigation Secrecy (2019) Surveillance, Privacy, and App Tracking (2020) Professor Oliva actively engages with policymakers and has contributed to amicus briefs in significant cases including Ruan v. United States. Her scholarship has been cited in legal proceedings and she regularly presents at major academic conferences including the Association of American Law Schools Annual Meeting. She has collaborated with scholars across disciplines including public health researchers, medical ethicists, and data scientists to address complex challenges at the intersection of law, technology, and healthcare.
Patrick T. Dowling, M.D., M.P.H., is the Kaiser Permanente Endowed Professor of Community Medicine and Chair of the UCLA Department of Family Medicine. He holds dual degrees from the Medical College of Ohio (1974) and the University of Michigan School of Public Health. Dr. Dowling's career spans over four decades in family medicine, residency training, and health policy advocacy, with a focus on underserved populations. He has directed residency programs at Cook County Hospital, Brown University, and Harbor-UCLA Medical Center before leading UCLA's Family Medicine department since 1998. His research emphasizes health policy, chronic disease management, cross-cultural medicine, and integrating substance abuse treatment into primary care. He co-founded UCLA's IMG pathway program to train bilingual (English-Spanish) international medical graduates for underserved areas. Dr. Dowling has advised the National Health Service Corps and LA County Public Health Commission, and currently serves on Drew University's Board of Trustees. Publications highlight systemic barriers to healthcare access, physician practice location determinants, opioid epidemic responses, and community-based participatory research. His work bridges medical education innovation with socioeconomic health equity, reflecting lifelong commitment to universal healthcare access inspired by his early work with Cesar Chavez's United Farm Workers Clinics.
John Monterosso is an Associate Professor of Psychology at the University of Southern California, specializing in addiction, motivation, and decision-making research. His work explores the neurocognitive mechanisms underlying impulse control and reward processing, with particular focus on substance use disorders and behavioral interventions. Monterosso's research integrates behavioral experiments with neuroimaging to examine decision-making processes in addiction contexts. His lab investigates how immediate rewards influence behavior and how cognitive control mechanisms can be harnessed for addiction treatment. Recent work examines the impact of e-cigarette flavors on appeal and sensory perception, obesity medication perceptions, and neural correlates of value representation. With collaborations spanning public health and neuroscience, his publications demonstrate consistent focus on translating basic psychological research into clinical applications. The methodological progression shows increasing sophistication in neuroimaging techniques and large-scale behavioral studies examining substance use patterns across diverse populations.
Anita Hubley is a Professor at the University of British Columbia's Faculty of Education, Department of Educational and Counselling Psychology, and Special Education (ECPS). She serves as MERM Program Coordinator and directs the Adult Development and Psychometrics Lab. Her work focuses on psychometric test development/validation and quality of life research across adult populations. Education: Ph.D. in Psychology (Human Assessment specialization), Carleton University (1995) M.A. in Psychology (Lifespan Development and Aging), University of Victoria (1991) Pre-doctoral training at Geriatric Assessment Unit (Ottawa) and Neuropsychological Assessment Unit (Ottawa) Her research integrates psychometric theory with practical applications in aging populations, homeless/vulnerably housed individuals, and neuropsychological assessment tools. Key contributions include developing the Memory Test for Older Adults (MTOA), Hubley Depression Scale for Older Adults (HDS-OA), Quality of Life in Homeless and Hard-to-House Individuals (QoLHHI), and Subjective Age Identity Scale (SAIS). Scientific Awards: Killam Teaching Prize (2017) Distinguished Reviewer, Buros Institute of Mental Measurements (2013) She has taught graduate courses in Psychological Assessment, Measurement Principles, Scale Development, and Applied Neuropsychology, emphasizing ethical testing practices and response process research. Her lab's work on test adaptation for marginalized populations has informed international measurement standards.
Roxane de la Sablonnière is a Full Professor in the Department of Psychology at the University of Montreal, affiliated with the Faculty of Arts and Sciences. She directs the CSI—Laboratory on Social Change and Identity and is a member of the CÉCD—Centre for the Study of Democratic Citizenship and the CIRCA—Interdisciplinary Research Centre on the Brain and Learning. Her research focuses on social change, cultural identities, intercultural relations, and the psychological impacts of crises like the COVID-19 pandemic. She has advised over 20 graduate students and led numerous research projects funded by agencies such as the Fonds de recherche du Québec (FRQ) and the Social Sciences and Humanities Research Council (SSHRC). Education & Research Focus : Her work examines how rapid societal changes affect individuals, particularly in contexts of immigration, policy shifts (e.g., multiculturalism, secularism), and Indigenous communities. Recent studies include longitudinal analyses of pandemic-related behaviors, identity integration processes, and the role of cognitive strategies in managing conflicting identities. Grants & Collaborations : She leads projects like "S'engager pour mieux aller!" (FRQS-funded) and contributes to strategic networks such as the Centre pour l'Étude de la Citoyenneté Démocratique (CÉCD). Her research integrates psychology with sociology, leveraging mixed methods (e.g., text mining, longitudinal tracking) to address societal challenges. Labs & Teams : As CSI director, she oversees projects on social change dynamics and identity reconstruction. Her work bridges academic and applied domains, influencing policy debates on integration, public health, and community resilience.
Professor Dhiraj Murthy holds appointments in the Moody College of Communication , Sociology , and School of Information at the University of Texas at Austin. He earned a Ph.D. in Sociology from the University of Cambridge. His research focuses on social media, digital methods, health communication, and disaster response. He directs the Computational Media Lab , a leading research group with over 20 students, and co-edits the journal Big Data & Society . Notably, he authored the seminal book Twitter: Social Communication in the Twitter Age (2013/2018), which won the ALA CHOICE Prize. Dr. Murthy's work has been funded by NIH, NSF, and other major grants, including studies on e-cigarette marketing, disaster informatics, and AI-driven disinformation detection. He also serves on advisory boards for MediaWell and chairs international social media conferences. Education : Ph.D. in Sociology, University of Cambridge. Grants : Over $5M from NIH, NSF, and UT Austin’s Good Systems initiative for projects like 'AI Technologies to Curb Disinformation' and 'E-cigarette Use Among Mexican American Students.' Labs/Teams : Computational Media Lab (UT Austin), focusing on AI, social media analytics, and health research. Awards : Stanford University’s 2023 Top 2% Global Scientists in Communication & Media Studies and Sociology, ALA CHOICE Prize (2018), and multiple NIH/NSF grants. His work bridges sociology, media studies, and computational methods to address societal challenges like health disparities and misinformation.
Samantha J. Harris, PhD, MPA, is an Assistant Scientist in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Her primary appointment is with the Bloomberg Overdose Prevention Initiative, where she leads state-level evaluations in Kentucky and New Mexico, focusing on overdose prevention and implementation of harm reduction policies. Institution: Johns Hopkins University School: Bloomberg School of Public Health Department: Department of Health Policy and Management Position: Assistant Scientist Education: PhD in Health Policy, University of Georgia, 2021 MPA in Health Policy, University of Kentucky, 2016 BA in Arts Administration, University of Kentucky, 2014 Postdoctoral Training, Johns Hopkins Bloomberg School of Public Health Samantha Harris's research centers on improving access to mental health and substance use treatment, particularly through public insurance programs like Medicaid and Medicare. Her work applies mixed-methods approaches to evaluate policies related to harm reduction, overdose prevention, and service delivery within the criminal legal system. She has a strong interest in aging and health, opioid and alcohol use disorders, and equitable access to care. Her recent publications highlight trends in Medicare coverage for methadone and buprenorphine, implementation of syringe services programs, and attitudes toward decriminalization policies. Her work spans qualitative and quantitative methods, often focusing on policy impact and implementation barriers at the state level. Scientific Contributions: Lead researcher on rapid-cycle evaluations of overdose prevention programs Co-Investigator on NIH, SAMHSA, and privately funded projects Frequent collaborator with interdisciplinary teams and state agencies Harris has served in policy-focused fellowship placements and contributes to high-impact journals such as Health Affairs and Drug and Alcohol Dependence . She advises on policy evaluation and health services research but no formal students are listed. She is actively involved in the Bloomberg Overdose Prevention Initiative, working closely with Dr. Brendan Saloner and Dr. Sachini Bandara. Her lab or team is embedded within this initiative, conducting real-time assessments of innovative state policies to reduce fatal overdoses.
Markus Heilig is a Professor of Psychiatry and Head of the Department of Biomedical and Clinical Sciences (BKV) at Linköping University. He serves as Director of the Center for Social and Affective Neuroscience (CSAN), integrating basic and clinical neuroscience to address addictive and affective disorders. His work bridges neuropharmacology, molecular psychiatry, and clinical trials. Linköping University (Current) Center for Social and Affective Neuroscience (CSAN) (Director) Wallenberg Center for Molecular Medicine (Collaborator) His research focuses on alcohol dependence mechanisms, stress-neurotransmitter interactions (e.g., CRF, substance P, endocannabinoids), and personalized medicine approaches. Using animal models and human neuroimaging (fMRI), his lab explores epigenetic changes in frontal lobe and amygdala neurons that drive compulsive alcohol use. Recent publications highlight his work on endocannabinoid modulation for PTSD treatment, neural correlates of reward choices, and pharmacological interventions targeting GABA and opioid receptors. His studies often combine brain imaging, behavioral analysis, and pharmacology. Scientific awards include the 2019 Wallenberg Clinical Scholar grant and 2017 CAN/Nordic Drugs prizes. Heilig's research is supported by Vetenskapsrådet (SEK 57 million center funding) and international donations like the Andrew J. Bock Memorial Fund.
Dr. Sara McMenamin is an Associate Professor at the Herbert Wertheim School of Public Health & Human Longevity Science at UC San Diego. She serves as the Associate Director of the MPH program and Interim Assistant Dean for Undergraduate Education . Her research focuses on state-level policies addressing tobacco use and preventive services, particularly health insurance coverage for tobacco dependence treatment in California and nationally. She also co-chairs the California Health Benefits Review Program , evaluating proposed health insurance legislation's medical, cost, and public health impacts. Her work spans public health policy analysis , health insurance mandate evaluations, and tobacco control strategies. Key areas include analyzing the effects of tobacco tax increases (e.g., Proposition 56), tracking smoking trends among youth and adults, and investigating the interplay between e-cigarette use and smoking cessation. She has contributed to studies on fertility preservation mandates, telemedicine for substance use disorders, and health equity in insurance access. Recent research highlights include assessing declines in youth smoking despite e-cigarette surges, evaluating tobacco policy coverage changes in California, and projecting future cigarette consumption trends. Her work often bridges policy implementation and population health outcomes, emphasizing evidence-based approaches. Dr. McMenamin collaborates with interdisciplinary teams and state agencies to translate research into actionable policies. Her contributions span over 150 peer-reviewed publications, with frequent media and policy engagement (e.g., cited in 14+ news outlets for key studies).
Dr. Rodolfo J. Flores serves as an Assistant Professor in the Department of Psychology within the College of Liberal Arts at the University of Texas at El Paso (UTEP). His primary research investigates neuromodulator function in the prefrontal cortex, with emphasis on acetylcholine and dynorphin systems during motivational conflict, stress responses, and addiction pathways. He employs advanced optogenetic and biosensor technologies to dissect neural circuitry underlying psychiatric conditions. Dr. Flores earned his Ph.D. in Social Cognitive and Neuroscience from UTEP in 2019, followed by postdoctoral training at the National Institute of Mental Health (NIMH). His work bridges molecular neuroscience with behavioral outcomes, focusing on how stress and substance exposure alter prefrontal cortical function. His research portfolio demonstrates consistent high-impact publication in top neuroscience journals including Nature Neuroscience , Neuron , and Psychoneuroendocrinology . Current work examines opioid neuropeptide dynamics, nicotine-alcohol interactions, and sex-specific hormonal influences on addiction behaviors. Methodologically, he specializes in genetically encoded biosensors and circuit-level manipulations to study threat processing and reward pathways. Dr. Flores teaches graduate and undergraduate courses including PSYC 4341 (Motivation & Emotion), thesis/dissertation supervision (PSYC 5395/6395), and research applications courses. His lab actively trains students through undergraduate research (RSRC 4033) and independent study opportunities (PSYC 4352).
Ana Adan Puig is a University Professor in the Department of Clinical Psychology and Psychobiology at the University of Barcelona's Faculty of Psychology. She serves as Academic Secretary of her department and is a member of the Board of Directors of the Institute of Neurosciences of the University of Barcelona (UBNEURO). Her research focuses on psychobiology, neuropsychology, and dual disorders (comorbid mental illness and substance use disorders), with emphasis on circadian rhythms, clinical outcomes, and neurobiological mechanisms. Education: Holds dual bachelor's degrees in Psychology from the Autonomous University of Barcelona (1986) and University of Barcelona (1988), followed by a doctoral degree in Psychology from the University of Barcelona (1995). Teaching: Over the past five years has taught courses including Psychopharmacology, Neurophysiology, Neuropsychology of Development and Dementias, and Sleep Disorders at the University of Barcelona. Research Projects: Lead investigator (IP) of the 2016-2019 PSI2015-65026-P project on Psychobiology of Dual Disorders. Collaborated in several initiatives including the DIANA project studying pandemic mental health impacts. Doctoral Supervision: Advised four PhD candidates whose research addressed topics like personality profiles in dual diagnosis patients, circadian rhythm influences in addiction treatment, and neurocognitive performance in dual disorder patients. Publications: Over 30 indexed articles focusing on schizophrenia-spectrum disorders, substance use comorbidity, circadian rhythm dysregulation, and mental health outcomes.
Christopher Conway serves as Associate Professor of Psychology at Fordham University's College of Arts and Sciences, where he directs the Bronx Personality (B-PER) Lab. His research investigates borderline personality disorder, anxiety, depression, and distress tolerance using experience sampling methods and longitudinal designs. The lab examines personality development across key transitions such as romantic breakups and financial strain. 2007 BS in Psychology and Spanish, Duke University 2009 MA in Clinical Psychology, University of California, Los Angeles 2013 PhD in Clinical Psychology, University of California, Los Angeles Conway's work centers on distress tolerance as a protective factor against self-injurious behaviors, momentary personality processes using ecological assessment, and the HiTOP consortium 's dimensional classification of psychopathology. His lab develops quantitative models linking personality dimensions to clinical outcomes, with emphasis on how stressors trigger symptom changes. Recent publications reveal neuroticism's specific association with broadband internalizing symptoms rather than narrowband anxiety or anhedonia. His publications demonstrate consistent focus on transdiagnostic mechanisms and dimensional classification systems . Key trends include validating the HiTOP framework across cultures, examining distress tolerance in substance use contexts across four continents, and developing within-person models of self-injury using registered report methodology. Professional affiliations include: Society for Research on Psychopathology Association for Psychological Science Association for Behavioral and Cognitive Therapies Association for Research in Personality Conway advises multiple graduate students in the B-PER Lab and leads several active studies including MOMENT (Measuring Our Momentary Emotions and Negative Thoughts), DENEM (Daily Experiences of Negative Emotions), and READI (Responses to Emotions And Daily Interactions). His lab participates in the multinational Cross-cultural Addictive Behaviors Study examining distress tolerance across seven countries. All research materials follow open science principles through his OSF repository. The B-PER Lab maintains active research programs examining personality development through: 3-year longitudinal Multiyear Adult Personality Project (MAPP) Cross-cultural Addictive Behaviors Study (CABS) Daily emotion regulation projects using smartphone-based assessments
Dr. Sara J Becker is a licensed clinical psychologist and implementation scientist at Northwestern University's Feinberg School of Medicine. She serves as the Inaugural Director of the Center for Dissemination and Implementation Science within the Institute for Public Health and Medicine (IPHAM) and holds the Alice Hamilton Professor of Psychiatry title. Her work bridges research and practice, focusing on equitable adoption of evidence-based treatments in community and clinical settings. Education: BA from Dartmouth College (2000), PhD in Clinical Psychology from Duke University (2009), internship at McLean Hospital/Harvard Medical School (2009), and postdoctoral fellowship at Brown University (2011). Dr. Becker’s research spans patient-focused dissemination strategies (e.g., technology-assisted interventions) and provider-focused implementation approaches (e.g., workforce development). Her recent publications highlight innovations in youth substance use treatment, cancer care, HIV prevention, and school-based mental health interventions, emphasizing equitable healthcare access. She has received prestigious awards, including the NIDA MERIT Award (2021) and the Society for Implementation Research Collaboration’s Best Research Symposium Award (2022). Dr. Becker co-leads two NIH-funded centers advancing implementation science and mentors extensively in the field. Scientific Advisory Roles: Substance Abuse and Mental Health Services Administration (2023-2024) NIDA Merit Award Advisory Board (2022-2023) Dr. Becker actively contributes as an editorial board member for Contemporary Clinical Trials and Journal of Substance Use & Addiction Treatment . She also serves on national conference planning committees and NIH review panels.
Benjamin Druss is a Professor and Rosalynn Carter Chair in Mental Health at Emory University’s Rollins School of Public Health, Department of Health Policy and Management. He is a psychiatrist integrating mental health, physical health, and public health. His research focuses on improving care access/outcomes for populations with serious mental illnesses and medical comorbidities. He serves on JAMA Psychiatry’s editorial board and previously on NIMH’s National Advisory Council. Education: MD, New York University MPH, Yale University Research Interests: Health policy for mental health systems Social determinants of mental health Psychosis and comorbidity mechanisms Healthcare access disparities Articles Trends: Recent work examines opioid use patterns, mental health policy impacts, and neighborhood effects on psychiatric outcomes. Over 15 years of publications consistently address disparities in mental health care access and systemic solutions. Awards: APA Health Services Research Senior Scholar Award Carl Taube Award for Lifetime Contribution NAMI Exemplary Psychiatrist Award Advising/Grants: Leads research on mental health workforce resilience and Medicaid policy. Courses taught include mental health/medical policy, public mental health case studies, and dissertation guidance.
